Nuchal translucency measurements are highly correlated in both mono- and dichorionic twin pairs

被引:18
作者
Wojdemann, KR
Larsen, SO
Shalmi, AC
Sundberg, K
Tabor, A
Christiansen, M [1 ]
机构
[1] Statens Serum Inst, Dept Clin Biochem, DK-2300 Artillerivej S, Denmark
[2] Hvidovre Univ Hosp, Dept Obstet & Gynecol, Copenhagen, Denmark
[3] Rigshosp, Dept Ultrasound Obstet, Copenhagen, Denmark
关键词
Down syndrome; first trimester; nuchal translucency; serum markers; twins;
D O I
10.1002/pd.1382
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objectives To establish the distribution of serological and ultrasound first-trimester Down syndrome markers in twins and identify correlations of significance for risk calculation. Methods Nuchal translucency (NT), PAPP-A and beta hCG data were extracted from 181 twin pregnancies (31 mono- and 150 dichorionic) with a normal outcome. All pregnancies were consecutively and prospectively included and examined in the Copenhagen First-Trimester Study. The variance of the sum and the difference of log MoM NT values in twin pairs was used to calculate the correlation. Results The serological markers did not correlate and were nearly twice the value seen in singleton pregnancies with a median PAPP-A MoM of 2.14 and a median free beta hCG MoM of 2.06. Chorionicity was not found to influence the level of biochemical markers. In all twin pairs (r = 0.343, p < 0.001, F-test), as well as mono- (r = 0.404, p = 0.011, F-test) and dichorionic twins (r = 0.316, p < 0.001, F-test) there was a significant correlation between log MoM NT in each pair. Conclusion As the NT values of fetuses in subsequent pregnancies from the same woman do not correlate, the correlation between NTs in twins reflects that the NT is influenced by placental and maternal factors specific for the particular pregnancy, for example, nutrient supply or vascularisation. The correlation may be useful to improve the precision of the prenatal risk assessment for Down syndrome in first-trimester twin pregnancies. The serological markers were elevated in the examined twins as previously described. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:218 / 220
页数:3
相关论文
共 15 条
[1]   First-trimester maternal serum PAPP-A, SP1 and M-CSF levels in normal and trisomic twin pregnancies [J].
Bersinger, NA ;
Noble, P ;
Nicolaides, KH .
PRENATAL DIAGNOSIS, 2003, 23 (02) :157-162
[2]   BIRTH-WEIGHT - NATURE OR NURTURE [J].
BROOKS, AA ;
JOHNSON, MR ;
STEER, PJ ;
PAWSON, ME ;
ABDALLA, HI .
EARLY HUMAN DEVELOPMENT, 1995, 42 (01) :29-35
[3]   Down's syndrome screening in twins [J].
Cuckle, H .
JOURNAL OF MEDICAL SCREENING, 1998, 5 (01) :3-4
[4]  
Larsen SO, 1998, PRENATAL DIAG, V18, P706, DOI 10.1002/(SICI)1097-0223(199807)18:7<706::AID-PD338>3.0.CO
[5]  
2-W
[6]   EARLY AND SIMPLE DETERMINATION OF CHORIONIC AND AMNIOTIC TYPE IN MULTIFETAL GESTATIONS IN THE 1ST 14 WEEKS BY HIGH-FREQUENCY TRANSVAGINAL ULTRASONOGRAPHY [J].
MONTEAGUDO, A ;
TIMORTRITSCH, IE ;
SHARMA, S .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (03) :824-829
[7]  
Nicolaides KH., 2004, The 11-13+6 weeks scan
[8]   Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A in twin pregnancies in the first trimester [J].
Niemimaa, M ;
Suonpää, M ;
Heinonen, S ;
Seppälä, M ;
Bloigu, R ;
Ryynänen, M .
PRENATAL DIAGNOSIS, 2002, 22 (03) :183-185
[9]   Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience [J].
Spencer, K ;
Nicolaides, KH .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2003, 110 (03) :276-280
[10]   Between pregnancy biological variability of first trimester markers of Down syndrome: implications for screening in subsequent pregnancies [J].
Spencer, K .
PRENATAL DIAGNOSIS, 2001, 21 (06) :445-447